Multi-targeting the Entrance Door to Block HIV-1

Publisher： Bentham Science Publishers

E-ISSN： 1875-5852|5|1|3-15

ISSN： 1568-0053

Source： Current Drug Targets - Infectious Disorders, Vol.5, Iss.1, 2005-03, pp. : 3-15

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting HIV-1 integrase

By Yelle Jocelyn   Sauvé Gilles   Sayasith Khampoune  

Expert Opinion on Therapeutic Targets, Vol. 5, Iss. 4, 2001-08 ,pp. : 443-464

Informa Healthcare

Access to resources Recommend Favorite

HIV-1 entry inhibitors: closing the front door

By Tomkowicz Brian   Collman Ronald G  

Expert Opinion on Therapeutic Targets, Vol. 8, Iss. 2, 2004-04 ,pp. : 65-78

Informa Healthcare

Access to resources Recommend Favorite

Approaches to a Multitargeting Drug Development: First Profiled 3- Ethoxycarbonyl-1-aza-9-oxafluorenes Representing a Perspective Compound Class Targeting Alzheimer Disease Relevant Kinases CDK1, CDK5 and GSK-3&bgr;

By  

Medicinal Chemistry, Vol. 10, Iss. 1, 2014-02 ,pp. : 90-97

Bentham Science Publishers

Access to resources Recommend Favorite

HIV-1 targeting of IFN regulatory factors

By Remoli Anna Lisa   Marsili Giulia   Sgarbanti Marco   Perrotti Edvige   Fragale Alessandra   Orsatti Roberto   Battistini Angela  

Future Virology, Vol. 6, Iss. 12, 2011-12 ,pp. : 1397-1405

Future Medicine

Access to resources Recommend Favorite

Targeting TNF-Alpha in HIV-1 Infection

By  

Current Drug Targets, Vol. 17, Iss. 1, 2016-01 ,pp. : 15-22

Bentham Science Publishers

Access to resources Recommend Favorite